Patients with retinal vascular occlusion had an elevated risk for Alzheimer’s disease and related dementias, new research shows.

The eyes are often said to be a window to the soul. This study suggests they may offer a better view of the mind. In A ...

Panelists discuss how aflibercept 8 mg maintains a safety profile similar to 2 mg and how workflow, systemic risk, and ...

Please provide your email address to receive an email when new articles are posted on . EXN407 met primary endpoints of safety and tolerability and also demonstrated decreases in vascular leakage and ...

Please provide your email address to receive an email when new articles are posted on . According to Nayak, Axpaxli (axitinib intravitreal implant) is “a single injection, a single completely ...

Vessel density in the deep capillary plexus reflects disease activity and structural involvement in thyroid eye disease.

Exonate Ltd. is preparing to advance its eye drop candidate to treat retinal vascular diseases, EXN-407, into a phase IIb study following promising tolerability and early signs of efficacy in a phase ...

SEATTLE -- A drug targeting senescent cells in diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD) produced mixed outcomes in two separate clinical trials. The 48-week ...

Neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) are the leading causes of vision impairment in elderly patients and people living with diabetes, respectively.

Enrollment in 4D-150 Phase 3 wet AMD clinical trials exceeding expectations; 4FRONT-1 trial remains on track to complete enrollment in Q1 2026, ...